News Release

Heartburn medication recalls continue due to carcinogen concerns

Total recalls from three companies in less than a week
For Immediate Release

PHILADELPHIA -- The U.S. Food and Drug Administration (FDA) has confirmed today that the drug manufacturers Dr. Reddy’s and Perrigo have initiated a voluntary recall of all of their generic versions of Zantac (ranitidine) -- commonly used to treat heartburn -- due to carcinogen contamination. This comes less than a week after Sanofi issued a similar voluntary recall of all over the counter Zantac, also to treat heartburn.

U.S. PIRG Education Fund Consumer Watchdog Adam Garber issued the following statement in response to the news:

“Americans expect this medication to relieve heartburn, not potentially cause cancer. We urge everyone taking this medication to check if they’re using Dr. Reddy’s, Perrigo or Sanofi products and immediately consult their doctor.

“In the last 18 months we’ve seen two major classes of drugs, heartburn and blood pressure medication, recalled because they contain a probable cancer-causing impurity. The FDA must get to the bottom of why these impurities continue to appear and take action by increasing inspections to ensure contaminated drugs never reach patients.”

Support us

Your tax-deductible donation supports CoPIRG Foundation's work to educate the public on the issues that matter, especially when powerful special interests are blocking progress.

Learn More

You can also support CoPIRG Foundation’s work through bequests, contributions from life insurance or retirement plans, securities contributions and vehicle donations. 

CoPIRG Foundation is part of The Public Interest Network, which operates and supports organizations committed to a shared vision of a better world and a strategic approach to social change.